Patents Assigned to Combinatorx (Singapore) Pte. Ltd.
  • Publication number: 20110201665
    Abstract: The present invention provides compositions, methods, and kits for treating or preventing a viral infection (e.g., an infection caused by an influenza virus).
    Type: Application
    Filed: August 12, 2010
    Publication date: August 18, 2011
    Applicants: COMBINATORX (SINGAPORE) PTE. LTD., EXCRX (Singapore) PTE. LTD. (F.K.A. CombinatoRx (Singapore) PTE. LTD.
    Inventors: Ralf Altmeyer, Geeta Sharma, Vishal Vikas Pendharkar, Danilal Champalal Sharma
  • Publication number: 20110028510
    Abstract: The present invention provides compositions, methods, and kits for treating or preventing a viral infection (e.g., an infection caused by an influenza virus).
    Type: Application
    Filed: February 18, 2010
    Publication date: February 3, 2011
    Applicants: COMBINATORX (SINGAPORE) PTE. LTD., EXCRX (Singapore) PTE. LTD. (F.K.A. CombinatoRx (Singapore) PTE. LTD.
    Inventors: Ralf Altmeyer, Geeta Sharma, Danilal Champalal Sharma, Vishal Vikas Pendharkar
  • Publication number: 20100092479
    Abstract: The present invention features compositions, methods, and kits useful in the treatment of viral diseases. In certain embodiments, the viral disease is caused by a single stranded RNA virus, a flaviviridae virus, or a hepatic virus. In particular embodiments, the viral disease is viral hepatitis (e.g., hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E).
    Type: Application
    Filed: August 17, 2009
    Publication date: April 15, 2010
    Applicant: CombinatoRx (Singapore) Pte. Ltd.
    Inventors: Lisa M. Johansen, Christopher M. Owens
  • Publication number: 20100009970
    Abstract: The present invention features compositions, methods, and kits useful in the treatment of viral diseases. In certain embodiments, the viral disease is caused by a single stranded RNA virus, a flaviviridae virus, or a hepatic virus. In particular embodiments, the viral disease is viral hepatitis (e.g., hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E) and the agent or combination of agents includes sertraline, a sertraline analog, UK-416244, or a UK-416244 analog. Also featured are screening methods for identification of novel compounds that may be used to treat a viral disease.
    Type: Application
    Filed: March 18, 2009
    Publication date: January 14, 2010
    Applicant: Combinatorx (Singapore) Pte. Ltd.
    Inventors: Lisa M. Johansen, Christopher M. Owens, Christina Mawhinney, Todd W. Chappell, Alexander T. Brown, Michael G. Frank, Michael A. Foley, Ralf Altmeyer, Yu Chen